$SRDX
SURMODICS INC

2021 Q3 Form 10-K Financial Statement

#000156459021058206 Filed on November 24, 2021

View on sec.gov

Income Statement

Concept 2021 Q3 2021 2020 Q3
Revenue $23.97M $105.1M $22.54M
YoY Change 6.33% 10.83% -26.85%
Cost Of Revenue $4.159M $16.68M $3.900M
YoY Change 6.64% 8.88% 6.56%
Gross Profit $19.81M $88.46M $18.64M
YoY Change 6.29% 11.2% -31.37%
Gross Profit Margin 82.65% 84.14% 82.69%
Selling, General & Admin $7.862M $29.78M $7.300M
YoY Change 7.7% 4.88% 1.53%
% of Gross Profit 39.68% 33.66% 39.16%
Research & Development $10.73M $44.53M $12.79M
YoY Change -16.1% -11.27% -11.91%
% of Gross Profit 54.16% 50.34% 68.62%
Depreciation & Amortization $2.407M $8.017M $1.870M
YoY Change 28.72% 10.38% 1.08%
% of Gross Profit 12.15% 9.06% 10.03%
Operating Expenses $19.71M $77.11M $20.64M
YoY Change -4.49% -1.87% -7.82%
Operating Profit $99.00K $11.35M -$1.993M
YoY Change -104.97% -1007.43% -151.43%
Interest Expense -$73.00K -$357.0K -$90.00K
YoY Change -18.89% -368.42% -137.5%
% of Operating Profit -73.74% -3.14%
Other Income/Expense, Net -$357.0K
YoY Change 75.86%
Pretax Income -$562.0K $6.346M -$2.080M
YoY Change -72.98% -536.45% -150.49%
Income Tax -$273.0K $2.109M $870.0K
% Of Pretax Income 33.23%
Net Earnings -$289.0K $4.237M -$2.946M
YoY Change -90.19% 277.29% -182.89%
Net Earnings / Revenue -1.21% 4.03% -13.07%
Basic Earnings Per Share $0.31 -$0.22
Diluted Earnings Per Share -$20.88K $302.9K -$0.22
COMMON SHARES
Basic Shares Outstanding 13.77M
Diluted Shares Outstanding 13.99M

Balance Sheet

Concept 2021 Q3 2021 2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $38.87M $38.87M $61.10M
YoY Change -36.38% -36.38% 10.49%
Cash & Equivalents $31.15M $31.15M $30.79M
Short-Term Investments $7.717M $7.717M $30.30M
Other Short-Term Assets $6.453M $6.453M $3.400M
YoY Change 89.79% 89.79% -12.82%
Inventory $6.760M $6.760M $5.966M
Prepaid Expenses $1.712M $1.418M
Receivables $9.169M $16.26M $7.675M
Other Receivables $1.912M $1.912M $2.400M
Total Short-Term Assets $70.26M $70.26M $86.61M
YoY Change -18.88% -18.87% 6.37%
LONG-TERM ASSETS
Property, Plant & Equipment $30.09M $32.53M $30.10M
YoY Change -0.04% -0.23% 1.19%
Goodwill $45.61M $27.19M
YoY Change 67.76% 3.87%
Intangibles $37.05M $13.28M
YoY Change 178.96% -6.63%
Long-Term Investments $2.002M $2.002M
YoY Change
Other Assets $3.718M $7.150M $4.269M
YoY Change -12.91% -21.43% 100.99%
Total Long-Term Assets $124.3M $124.3M $82.16M
YoY Change 51.34% 51.26% 4.73%
TOTAL ASSETS
Total Short-Term Assets $70.26M $70.26M $86.61M
Total Long-Term Assets $124.3M $124.3M $82.16M
Total Assets $194.6M $194.6M $168.8M
YoY Change 15.3% 15.28% 5.57%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.783M $1.783M $1.515M
YoY Change 17.69% 18.87% -27.34%
Accrued Expenses $4.905M $13.39M $5.547M
YoY Change -11.57% 9.71% -40.99%
Deferred Revenue
YoY Change
Short-Term Debt $10.00M $10.00M $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $29.82M $29.82M $18.89M
YoY Change 57.82% 57.75% -6.52%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $11.65M $21.95M $8.020M
YoY Change 45.25% 16.76% 45.5%
Total Long-Term Liabilities $11.65M $21.95M $8.020M
YoY Change 45.25% 16.76% 45.5%
TOTAL LIABILITIES
Total Short-Term Liabilities $29.82M $29.82M $18.89M
Total Long-Term Liabilities $11.65M $21.95M $8.020M
Total Liabilities $54.51M $54.51M $37.71M
YoY Change 44.55% 44.58% 0.96%
SHAREHOLDERS EQUITY
Retained Earnings $116.1M $111.8M
YoY Change 3.79% 1.01%
Common Stock $22.29M $16.05M
YoY Change 38.87% 40.63%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $140.1M $140.1M $131.1M
YoY Change
Total Liabilities & Shareholders Equity $194.6M $194.6M $168.8M
YoY Change 15.3% 15.28% 5.57%

Cashflow Statement

Concept 2021 Q3 2021 2020 Q3
OPERATING ACTIVITIES
Net Income -$289.0K $4.237M -$2.946M
YoY Change -90.19% 277.29% -182.89%
Depreciation, Depletion And Amortization $2.407M $8.017M $1.870M
YoY Change 28.72% 10.38% 1.08%
Cash From Operating Activities $889.0K $15.39M $1.310M
YoY Change -32.14% 9.84% -89.54%
INVESTING ACTIVITIES
Capital Expenditures -$2.405M -$6.279M -$1.040M
YoY Change 131.25% -271.04% -60.15%
Acquisitions $39.55M
YoY Change
Other Investing Activities -$39.48M -$18.96M -$6.160M
YoY Change 540.86% 251.09% -30.47%
Cash From Investing Activities -$41.88M -$25.24M -$7.200M
YoY Change 481.69% 178.38% -37.23%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $3.128M
YoY Change 93.68%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 10.03M 10.23M 160.0K
YoY Change 6168.13% -320.03% -64.44%
NET CHANGE
Cash From Operating Activities 889.0K 15.39M 1.310M
Cash From Investing Activities -41.88M -25.24M -7.200M
Cash From Financing Activities 10.03M 10.23M 160.0K
Net Change In Cash -30.96M 368.0K -5.730M
YoY Change 440.38% -13.21% -482.0%
FREE CASH FLOW
Cash From Operating Activities $889.0K $15.39M $1.310M
Capital Expenditures -$2.405M -$6.279M -$1.040M
Free Cash Flow $3.294M $21.67M $2.350M
YoY Change 40.17% 109.58% -84.47%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021 dei Document Transition Report
DocumentTransitionReport
false
CY2020Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q3 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2021-01-31#OtherAssets
CY2021Q3 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesCurrent
CY2021Q3 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y7M6D
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y7M6D
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y6M
CY2021 dei Document Annual Report
DocumentAnnualReport
true
CY2021 dei Entity File Number
EntityFileNumber
0-23837
CY2021 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MN
CY2021 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
41-1356149
CY2021 dei Entity Address Address Line1
EntityAddressAddressLine1
9924 West 74th Street
CY2021 dei Entity Address City Or Town
EntityAddressCityOrTown
Eden Prairie
CY2021 dei Entity Address State Or Province
EntityAddressStateOrProvince
MN
CY2021 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
55344
CY2021 dei City Area Code
CityAreaCode
952
CY2021 dei Local Phone Number
LocalPhoneNumber
500-7000
CY2021 dei Security12b Title
Security12bTitle
Common Stock, $0.05 par value
CY2021 dei Entity Small Business
EntitySmallBusiness
false
CY2021 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2021 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2021 dei Entity Shell Company
EntityShellCompany
false
CY2021Q1 dei Entity Public Float
EntityPublicFloat
752000000
CY2021Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
13905000
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
30785000
CY2020Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
130000
CY2020Q3 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
6108000
CY2019 us-gaap Interest Expense
InterestExpense
152000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
7592000
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
10227000
CY2020Q3 us-gaap Inventory Net
InventoryNet
5966000
CY2020Q3 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
2391000
CY2020Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3370000
CY2020Q3 us-gaap Assets Current
AssetsCurrent
86608000
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
30103000
CY2021Q3 us-gaap Available For Sale Securities Noncurrent
AvailableForSaleSecuritiesNoncurrent
2002000
CY2021Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
5867000
CY2020Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
7315000
CY2021Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
37054000
CY2020Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
13283000
CY2021Q3 us-gaap Goodwill
Goodwill
45606000
CY2020Q3 us-gaap Goodwill
Goodwill
27185000
CY2021Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3718000
CY2020Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4269000
CY2021Q3 us-gaap Assets
Assets
194592000
CY2020Q3 us-gaap Assets
Assets
168763000
CY2021Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
1783000
CY2020Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
1515000
CY2021Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
8480000
CY2020Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
6630000
CY2021Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4905000
CY2020Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5547000
CY2021Q3 us-gaap Short Term Borrowings
ShortTermBorrowings
10000000
CY2021Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
4647000
CY2020Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
5200000
CY2020Q3 us-gaap Liabilities Current
LiabilitiesCurrent
18892000
CY2021Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
2742000
CY2020Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
8020000
CY2020Q3 us-gaap Liabilities
Liabilities
37708000
CY2020Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.05
CY2020Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
450000
CY2020Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.05
CY2020Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
45000000
CY2020Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
13672000
CY2020Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
13672000
CY2021 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-10000
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
30785000
CY2020Q3 us-gaap Common Stock Value
CommonStockValue
684000
CY2020Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
15369000
CY2020Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
3174000
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
111828000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
131055000
CY2020Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
168763000
CY2021 us-gaap Business Combination Integration Related Costs
BusinessCombinationIntegrationRelatedCosts
1049000
CY2019 us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
890000
CY2020 us-gaap Interest Expense
InterestExpense
133000
CY2020 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-248000
CY2019 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
134000
CY2020 srdx Loss Gain On Strategic Investments And Other
LossGainOnStrategicInvestmentsAndOther
478000
CY2019 srdx Loss Gain On Strategic Investments And Other
LossGainOnStrategicInvestmentsAndOther
-10000
CY2019 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1089000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
7558000
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-34000
CY2019 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.57
CY2019 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.55
CY2019 us-gaap Net Income Loss
NetIncomeLoss
7592000
CY2019 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
64000
CY2020 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1115000
CY2019 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
441000
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2790000
CY2018Q3 us-gaap Stockholders Equity
StockholdersEquity
108610000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
7592000
CY2019 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
282000
CY2019 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
2662000
CY2019 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5077000
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
122516000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
1123000
CY2020 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
2778000
CY2020 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
500000
CY2020 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
2430000
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5453000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
131055000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
4237000
CY2021 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1447000
CY2021 us-gaap Profit Loss
ProfitLoss
4237000
CY2020 us-gaap Profit Loss
ProfitLoss
1123000
CY2019 us-gaap Profit Loss
ProfitLoss
7592000
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
8017000
CY2020 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
7263000
CY2019 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
7312000
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5863000
CY2020 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5453000
CY2019 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5077000
CY2021 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
308000
CY2020 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
246000
CY2020 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
73000
CY2019 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
160000
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1139000
CY2019 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1088000
CY2020 us-gaap Payment For Contingent Consideration Liability Operating Activities
PaymentForContingentConsiderationLiabilityOperatingActivities
608000
CY2019 us-gaap Payment For Contingent Consideration Liability Operating Activities
PaymentForContingentConsiderationLiabilityOperatingActivities
2041000
CY2020 us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
-479000
CY2019 us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
7000
CY2019 us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
890000
CY2021 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-181000
CY2021 srdx Increase Decrease In Accounts Receivable And Contract With Customer Asset
IncreaseDecreaseInAccountsReceivableAndContractWithCustomerAsset
2480000
CY2021 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
818000
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2391000
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
264000
CY2021 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1406000
CY2021 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
210000
CY2021 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-1048000
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
15389000
CY2019 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-17000
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-25238000
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-9066000
CY2021 us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
10000000
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
3128000
CY2021 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
2751000
CY2020 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
137000
CY2021 srdx Payments For Acquisition Of In Process Research And Development
PaymentsForAcquisitionOfInProcessResearchAndDevelopment
150000
CY2021 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
1000000
CY2021 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
22723000
CY2021 us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
43317000
CY2021 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
39553000
CY2020 srdx Payments For Acquisition Of In Process Research And Development
PaymentsForAcquisitionOfInProcessResearchAndDevelopment
1000000
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
368000
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
160000
CY2021 us-gaap Interest Paid Net
InterestPaidNet
74000
CY2020 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1181000
CY2021 us-gaap Noncash Or Part Noncash Acquisition Debt Assumed1
NoncashOrPartNoncashAcquisitionDebtAssumed1
4071000
CY2019 srdx Non Cash Transaction Acquisition Of In Process Research And Development In Other Long Term Liabilities
NonCashTransactionAcquisitionOfInProcessResearchAndDevelopmentInOtherLongTermLiabilities
140000
CY2021Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
1295000
CY2021Q3 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
9718000
CY2021Q3 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
2000
CY2021Q3 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
7717000
CY2021Q3 us-gaap Available For Sale Securities Noncurrent
AvailableForSaleSecuritiesNoncurrent
2002000
CY2020Q3 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
30313000
CY2020Q3 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
19000
CY2020Q3 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
19000
CY2020Q3 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
30313000
CY2021Q3 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
0
CY2020Q3 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
0
CY2021 us-gaap Available For Sale Securities Gross Realized Gain Loss Net
AvailableForSaleSecuritiesGrossRealizedGainLossNet
0
CY2020 us-gaap Available For Sale Securities Gross Realized Gain Loss Net
AvailableForSaleSecuritiesGrossRealizedGainLossNet
0
CY2019 us-gaap Available For Sale Securities Gross Realized Gain Loss Net
AvailableForSaleSecuritiesGrossRealizedGainLossNet
0
CY2021Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
4165000
CY2020Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
3758000
CY2020Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
817000
CY2021Q3 us-gaap Inventory Net
InventoryNet
6760000
CY2020Q3 us-gaap Inventory Net
InventoryNet
5966000
CY2021Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1712000
CY2020Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1418000
CY2021Q3 srdx Irish Research And Development Credits Receivable
IrishResearchAndDevelopmentCreditsReceivable
1164000
CY2020Q3 srdx Irish Research And Development Credits Receivable
IrishResearchAndDevelopmentCreditsReceivable
1177000
CY2021Q3 srdx Cares Act Employee Retention Credit Receivable
CARESActEmployeeRetentionCreditReceivable
3577000
CY2020Q3 us-gaap Other Assets Miscellaneous Current
OtherAssetsMiscellaneousCurrent
775000
CY2021Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
6453000
CY2020Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3370000
CY2021 srdx Cares Act Employee Retention Credit Benefit
CARESActEmployeeRetentionCreditBenefit
3600000
CY2021Q3 srdx Cares Act Employee Retention Credit Receivable
CARESActEmployeeRetentionCreditReceivable
3600000
CY2020Q3 srdx Cares Act Employee Retention Credit Receivable
CARESActEmployeeRetentionCreditReceivable
3600000
CY2021 us-gaap Depreciation
Depreciation
4900000
CY2020 us-gaap Depreciation
Depreciation
4800000
CY2019 us-gaap Depreciation
Depreciation
4700000
CY2021Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
47716000
CY2020Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
42962000
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
30090000
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
30103000
CY2021Q3 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
53878000
CY2021Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
16824000
CY2021Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
37054000
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
4668000
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
4070000
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
3978000
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
3940000
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
2992000
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
16826000
CY2021Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
36474000
CY2020 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
0
CY2021 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
0
CY2019Q3 us-gaap Goodwill
Goodwill
26171000
CY2020 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
1014000
CY2020Q3 us-gaap Goodwill
Goodwill
27185000
CY2021 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
19089000
CY2021 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-668000
CY2021Q3 us-gaap Goodwill
Goodwill
45606000
CY2021 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2020 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2019 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2021Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3718000
CY2020Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4269000
CY2019 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2020 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2021 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2021Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
489000
CY2020Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
239000
CY2021Q3 srdx Accrued Clinical Study Expense Current
AccruedClinicalStudyExpenseCurrent
1667000
CY2020Q3 srdx Accrued Clinical Study Expense Current
AccruedClinicalStudyExpenseCurrent
2206000
CY2021Q3 srdx Accrued Purchases Current
AccruedPurchasesCurrent
1195000
CY2020Q3 srdx Accrued Purchases Current
AccruedPurchasesCurrent
647000
CY2021Q3 srdx Acquisition Of In Process Research And Development And Intangible Assets Current
AcquisitionOfInProcessResearchAndDevelopmentAndIntangibleAssetsCurrent
494000
CY2020Q3 srdx Acquisition Of In Process Research And Development And Intangible Assets Current
AcquisitionOfInProcessResearchAndDevelopmentAndIntangibleAssetsCurrent
1148000
CY2021Q3 srt Payables To Customers
PayablesToCustomers
112000
CY2020Q3 srt Payables To Customers
PayablesToCustomers
321000
CY2021Q3 us-gaap Construction Payable Current
ConstructionPayableCurrent
23000
CY2020Q3 us-gaap Construction Payable Current
ConstructionPayableCurrent
272000
CY2021Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
518000
CY2020Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
436000
CY2021Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
407000
CY2020Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
278000
CY2021Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4905000
CY2020Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5547000
CY2021Q3 srdx Deferred Consideration Liability Noncurrent
DeferredConsiderationLiabilityNoncurrent
5106000
CY2020Q3 srdx Deferred Consideration Liability Noncurrent
DeferredConsiderationLiabilityNoncurrent
2216000
CY2021Q3 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
817000
CY2021Q3 srdx Unrecognized Tax Benefits Including Accrued Interest And Penalties
UnrecognizedTaxBenefitsIncludingAccruedInterestAndPenalties
2538000
CY2020Q3 srdx Unrecognized Tax Benefits Including Accrued Interest And Penalties
UnrecognizedTaxBenefitsIncludingAccruedInterestAndPenalties
2464000
CY2021Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3188000
CY2020Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3340000
CY2021Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
11649000
CY2020Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
8020000
CY2021Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2435000
CY2020Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2508000
CY2021Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
518000
CY2020Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
436000
CY2021Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3188000
CY2020Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3340000
CY2021Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
3706000
CY2020Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
3776000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
657000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
671000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
685000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
699000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
604000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
892000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
4208000
CY2021Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
502000
CY2021Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
3706000
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13765000
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13552000
CY2019 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13389000
CY2021 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
224000
CY2020 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
260000
CY2019 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
390000
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13989000
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13812000
CY2019 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13779000
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
100000
CY2020 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
100000
CY2019 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
200000
CY2020Q3 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
1200000
CY2021Q3 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
7100000
CY2020Q3 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
6100000
CY2021Q3 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
25300000
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5863000
CY2020 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5453000
CY2019 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5077000
CY2021Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
8400000
CY2021 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y2M12D
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0040
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0141
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0275
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.43
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.39
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.34
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
14.71
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
14.13
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
17.89
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
711000
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
26.28
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
179000
CY2019 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
55.09
CY2019 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
13000
CY2019 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
22.03
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
6000
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
42.28
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
871000
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
32.18
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
299000
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
41.06
CY2020 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
125000
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
22.89
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
105000
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
41.69
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
940000
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
35.18
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
274000
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
40.95
CY2021 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
248000
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
24.22
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
44000
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
44.58
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
922000
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
39.39
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
402000
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
36.07
CY2020 srdx Income Tax Reconciliation Impact Of Cares Act
IncomeTaxReconciliationImpactOfCaresAct
1700000
CY2021 us-gaap Income Tax Reconciliation Nondeductible Expense Other
IncomeTaxReconciliationNondeductibleExpenseOther
187000
CY2020 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-1570000
CY2019 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
1355000
CY2021 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
108000
CY2020 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
42000
CY2019 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
192000
CY2021 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
87000
CY2020 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
90000
CY2019 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
41000
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
458000
CY2020 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-1438000
CY2019 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
1588000
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
1851000
CY2020 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-1336000
CY2019 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-1505000
CY2021 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-62000
CY2020 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
197000
CY2019 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-117000
CY2021 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-138000
CY2021 us-gaap Deferred Federal State And Local Tax Expense Benefit
DeferredFederalStateAndLocalTaxExpenseBenefit
1651000
CY2020 us-gaap Deferred Federal State And Local Tax Expense Benefit
DeferredFederalStateAndLocalTaxExpenseBenefit
-1139000
CY2019 us-gaap Deferred Federal State And Local Tax Expense Benefit
DeferredFederalStateAndLocalTaxExpenseBenefit
-1622000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2109000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2577000
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-34000
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
1333000
CY2020 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-305000
CY2019 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
1587000
CY2021 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-273000
CY2020 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-551000
CY2019 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-452000
CY2021 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
920000
CY2020 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
1571000
CY2020 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
212000
CY2019 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
156000
CY2021 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
1059000
CY2020 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
825000
CY2019 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
671000
CY2021 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
-544000
CY2020 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
-81000
CY2019 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
-163000
CY2021 srdx Income Tax Reconciliation Contingent Consideration Gain Expense And Related Foreign Currency Revaluation
IncomeTaxReconciliationContingentConsiderationGainExpenseAndRelatedForeignCurrencyRevaluation
3000
CY2019 srdx Income Tax Reconciliation Contingent Consideration Gain Expense And Related Foreign Currency Revaluation
IncomeTaxReconciliationContingentConsiderationGainExpenseAndRelatedForeignCurrencyRevaluation
-61000
CY2021 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
-35000
CY2020 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
17000
CY2019 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
44000
CY2021 us-gaap Income Tax Reconciliation Tax Contingencies
IncomeTaxReconciliationTaxContingencies
-150000
CY2020 us-gaap Income Tax Reconciliation Tax Contingencies
IncomeTaxReconciliationTaxContingencies
609000
CY2019 us-gaap Income Tax Reconciliation Tax Contingencies
IncomeTaxReconciliationTaxContingencies
770000
CY2020 us-gaap Income Tax Reconciliation Deductions Extraterritorial Income Exclusion
IncomeTaxReconciliationDeductionsExtraterritorialIncomeExclusion
88000
CY2019 us-gaap Income Tax Reconciliation Deductions Extraterritorial Income Exclusion
IncomeTaxReconciliationDeductionsExtraterritorialIncomeExclusion
150000
CY2021 srdx Income Tax Reconciliation Impact Of Cares Act
IncomeTaxReconciliationImpactOfCaresAct
-735000
CY2021 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
118000
CY2020 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
56000
CY2019 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
28000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2109000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2577000
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-34000
CY2020 srdx Income Tax Reconciliation Impact Of Cares Act
IncomeTaxReconciliationImpactOfCaresAct
1700000
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2021 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
900000
CY2020 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
400000
CY2019 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
500000
CY2021Q3 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
5106000
CY2020Q3 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
1964000
CY2021Q3 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
2130000
CY2020Q3 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
2029000
CY2021Q3 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
1572000
CY2020Q3 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
1858000
CY2021Q3 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1997000
CY2020Q3 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
2232000
CY2021Q3 us-gaap Deferred Tax Assets Investments
DeferredTaxAssetsInvestments
1782000
CY2020Q3 us-gaap Deferred Tax Assets Investments
DeferredTaxAssetsInvestments
1767000
CY2021Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
4319000
CY2020Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
3526000
CY2021Q3 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
3066000
CY2020Q3 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
3216000
CY2021Q3 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
618000
CY2020Q3 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
897000
CY2021Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
7253000
CY2020Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
6246000
CY2021Q3 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
3125000
CY2020Q3 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
7315000
CY2021Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
7300000
CY2020Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
2871000
CY2019Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
2323000
CY2021 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
15000
CY2020 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
58000
CY2021 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
8000
CY2020 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
1000
CY2021 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
458000
CY2020 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
664000
CY2021 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
449000
CY2020 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
173000
CY2021Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
2887000
CY2020Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
2871000
CY2021Q3 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
400000
CY2020Q3 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
600000
CY2019Q3 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
500000
CY2021 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
105136000
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
94864000
CY2019 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
100077000
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
8017000
CY2020 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
7263000
CY2019 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
7312000

Files In Submission

Name View Source Status
0001564590-21-058206-index-headers.html Edgar Link pending
0001564590-21-058206-index.html Edgar Link pending
0001564590-21-058206.txt Edgar Link pending
0001564590-21-058206-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
g0mewmyqvhvo000001.jpg Edgar Link pending
g0mewmyqvhvo000002.jpg Edgar Link pending
g2qaslceg4vv000001.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
srdx-10k_20210930.htm Edgar Link pending
srdx-10k_20210930_htm.xml Edgar Link completed
srdx-20210930.xsd Edgar Link pending
srdx-20210930_cal.xml Edgar Link unprocessable
srdx-20210930_def.xml Edgar Link unprocessable
srdx-20210930_lab.xml Edgar Link unprocessable
srdx-20210930_pre.xml Edgar Link unprocessable
srdx-ex1027_653.htm Edgar Link pending
srdx-ex21_7.htm Edgar Link pending
srdx-ex23_11.htm Edgar Link pending
srdx-ex311_12.htm Edgar Link pending
srdx-ex312_10.htm Edgar Link pending
srdx-ex321_8.htm Edgar Link pending
srdx-ex322_9.htm Edgar Link pending